{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:22:33Z","timestamp":1781083353519,"version":"3.54.1"},"reference-count":49,"publisher":"The Journal of Rheumatology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the distribution of patient-reported outcomes (PROs) in patients with axial spondyloarthritis (axSpA) initiating a tumor necrosis factor inhibitor (TNFi), to assess the proportion reaching PRO \u201cremission\u201d across registries and treatment series, and to compare patients registered to fulfill the modified New York (mNY) criteria for ankylosing spondylitis (AS) vs patients with nonradiographic axSpA (nr-axSpA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Fifteen European registries contributed PRO scores for pain, fatigue, patient global assessment (PtGA), Bath Ankylosing Spondylitis (AS) Disease Activity Index (BASDAI), Bath AS Functional Index (BASFI), and Health Assessment Questionnaire (HAQ) from 19,498 patients with axSpA. Changes in PROs and PRO remission rates (definitions: \u2264 20 mm for pain, fatigue, PtGA, BASDAI, and BASFI; \u2264 0.5 for HAQ) were calculated at 6, 12, and 24 months of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Heterogeneity in baseline characteristics and outcomes between registries were observed. In pooled data, 6 months after the start of a first TNFi, pain score was reduced by approximately 60% (median at baseline\/6\/12\/24 months: 65\/25\/20\/20 mm) in patients on treatment. Similar patterns were observed for fatigue (68\/32\/30\/25 mm), PtGA (66\/29\/21\/20 mm), BASDAI (58\/26\/21\/19 mm), BASFI (46\/20\/16\/16 mm), and HAQ (0.8\/0.4\/0.2\/0.2). Patients with AS (n = 3281) had a slightly better response than patients with nr-axSpA (n = 993). The Lund Efficacy Index (LUNDEX)-adjusted remission rates at 6 months for pain\/fatigue\/PtGA\/BASDAI\/BASFI\/HAQ were 39%\/30%\/38%\/34%\/35%\/48% for the AS cohort and 30%\/21%\/26%\/24%\/33%\/47% for the nr-axSpA cohort. Better PRO responses were seen with a first TNFi compared to a second and third TNFi.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with axSpA starting a TNFi achieved high PRO remission rates, most pronounced in those fulfilling the mNY criteria and for the first TNFi.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.220459","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:04:32Z","timestamp":1669917872000},"page":"1009-1019","source":"Crossref","is-referenced-by-count":11,"title":["One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment"],"prefix":"10.3899","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-6831","authenticated-orcid":false,"given":"Lykke Midtb\u00f8ll","family":"\u00d8rnbjerg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7854-1075","authenticated-orcid":false,"given":"Kathrine","family":"Rugbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-9457","authenticated-orcid":false,"given":"Stylianos","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-277X","authenticated-orcid":false,"given":"Simon Horskj\u00e6r","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2250-9348","authenticated-orcid":false,"given":"Ulf","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1952-8422","authenticated-orcid":false,"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8574-5567","authenticated-orcid":false,"given":"Neslihan","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1471-6467","authenticated-orcid":false,"given":"Ennio Giulio","family":"Favalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-1764","authenticated-orcid":false,"given":"Michael J.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-2840","authenticated-orcid":false,"given":"Brigitte","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7170-8802","authenticated-orcid":false,"given":"Elsa","family":"Vieira-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-7591","authenticated-orcid":false,"given":"Gareth T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Ionescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8065-3930","authenticated-orcid":false,"given":"Heikki","family":"Relas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-7347","authenticated-orcid":false,"given":"Carlos","family":"Sanchez-Piedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-9010","authenticated-orcid":false,"given":"Matija","family":"Tom\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arni Jon","family":"Geirsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8086-9915","authenticated-orcid":false,"given":"Irene","family":"van der Horst-Bruinsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0433-0616","authenticated-orcid":false,"given":"Johan","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6374-841X","authenticated-orcid":false,"given":"Anne Gitte","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8866-2310","authenticated-orcid":false,"given":"Lucie","family":"Nekvindova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2598-5806","authenticated-orcid":false,"given":"Haner","family":"Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-5344","authenticated-orcid":false,"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-7132","authenticated-orcid":false,"given":"Adrian","family":"Ciurea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-7860","authenticated-orcid":false,"given":"Karen Minde","family":"Fagerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-1365","authenticated-orcid":false,"given":"Maria Jos\u00e9","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-3314","authenticated-orcid":false,"given":"Gary J.","family":"Macfarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalin","family":"Codreanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5870-4663","authenticated-orcid":false,"given":"Kari","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2524-4883","authenticated-orcid":false,"given":"Manuel","family":"Pombo-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-9189","authenticated-orcid":false,"given":"Ziga","family":"Rotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-6505","authenticated-orcid":false,"given":"Bjorn","family":"Gudbjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8628-0119","authenticated-orcid":false,"given":"Tamara","family":"Rusman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-467X","authenticated-orcid":false,"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4229-6818","authenticated-orcid":false,"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"2023122105350786000_50.8.1009.1","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1097\/MD.0000000000000337","article-title":"Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis","volume":"93","author":"Kilic","year":"2014","journal-title":"Medicine"},{"key":"2023122105350786000_50.8.1009.2","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1644-6"},{"key":"2023122105350786000_50.8.1009.3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-019-0819-8","article-title":"The European Map of Axial Spondyloarthritis: capturing the patient perspective-an analysis of 2846 patients across 13 countries","volume":"21","author":"Garrido-Cumbrera","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"2023122105350786000_50.8.1009.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"2023122105350786000_50.8.1009.5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000053"},{"key":"2023122105350786000_50.8.1009.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210770"},{"key":"2023122105350786000_50.8.1009.7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160958"},{"key":"2023122105350786000_50.8.1009.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150372"},{"key":"2023122105350786000_50.8.1009.9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.rdc.2016.01.011","article-title":"Patient-reported outcomes in axial spondyloarthritis","volume":"42","author":"Nhan","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"2023122105350786000_50.8.1009.10","first-page":"61","article-title":"Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Heal Serv Insights"},{"key":"2023122105350786000_50.8.1009.11","first-page":"45","article-title":"Reuma.pt - the Rheumatic Diseases Portuguese Register","volume":"36","author":"Canh\u00e3o","year":"2011","journal-title":"Acta Reumatol Port"},{"key":"2023122105350786000_50.8.1009.12","first-page":"S163","article-title":"BIOBADASER, BIOBADAMERICA, and BIOBADADERM: safety registers sharing commonalities across diseases and countries","volume":"32","author":"Carmona","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2023122105350786000_50.8.1009.13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5152\/eurjrheum.2022.21060","article-title":"A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry","volume":"9","author":"\u00d6nen","year":"2022","journal-title":"Eur J Rheumatol"},{"key":"2023122105350786000_50.8.1009.14","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/rheumatology\/kez656","article-title":"Impact of discordance between patient\u2019s and evaluator\u2019s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis","volume":"59","author":"Michelsen","year":"2020","journal-title":"Rheumatology"},{"key":"2023122105350786000_50.8.1009.15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.biologicals.2019.10.009","article-title":"Efficacy and safety of original and biosimilar etanercept (SB4) in active rheumatoid arthritis - a comparison in a real-world national cohort","volume":"62","author":"Codreanu","year":"2019","journal-title":"Biologicals"},{"key":"2023122105350786000_50.8.1009.16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu252"},{"key":"2023122105350786000_50.8.1009.17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/CLEP.S99490","article-title":"The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO","volume":"8","author":"Ibfelt","year":"2016","journal-title":"Clinical Epidemiol"},{"key":"2023122105350786000_50.8.1009.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-005-0097-9"},{"key":"2023122105350786000_50.8.1009.19","first-page":"S188","article-title":"A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases","volume":"23","author":"Kvien","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2023122105350786000_50.8.1009.20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4081\/reumatismo.2011.155","article-title":"GISEA: an Italian biological agents registry in rheumatology","volume":"63","author":"Lapadula","year":"2011","journal-title":"Reumatismo"},{"key":"2023122105350786000_50.8.1009.21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12891-015-0805-x","article-title":"The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment","volume":"16","author":"Macfarlane","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"2023122105350786000_50.8.1009.22","first-page":"958","article-title":"Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA","volume":"27","author":"Pavelka","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"2023122105350786000_50.8.1009.23","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s10067-015-3066-z","article-title":"Retention of the second-line biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis failing one tumor necrosis factor alpha inhibitor: data from the BioRx.si registry","volume":"34","author":"Rotar","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2023122105350786000_50.8.1009.24","first-page":"S195","article-title":"Rheumatoid arthritis registries in Sweden","volume":"23","author":"van Vollenhoven","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2023122105350786000_50.8.1009.25","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20575"},{"key":"2023122105350786000_50.8.1009.26","first-page":"167","article-title":"The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation","volume":"30","author":"Bruce","year":"2003","journal-title":"J Rheumatol"},{"key":"2023122105350786000_50.8.1009.27","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"2023122105350786000_50.8.1009.28","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2023122105350786000_50.8.1009.29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201142"},{"key":"2023122105350786000_50.8.1009.30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00296-017-3920-1","article-title":"Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)","volume":"38","author":"Madsen","year":"2018","journal-title":"Rheumatol Int"},{"key":"2023122105350786000_50.8.1009.31","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F"},{"key":"2023122105350786000_50.8.1009.32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.21570","article-title":"The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden","volume":"54","author":"Kristensen","year":"2006","journal-title":"Arthritis Rheumatol"},{"key":"2023122105350786000_50.8.1009.33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204102"},{"key":"2023122105350786000_50.8.1009.34","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/acr.22594","article-title":"Impact of certolizumab pegol on patient-reported outcomes in patients with axial spondyloarthritis","volume":"67","author":"Sieper","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2023122105350786000_50.8.1009.35","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/kex174","article-title":"Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA","volume":"56","author":"van der Heijde","year":"2017","journal-title":"Rheumatology"},{"key":"2023122105350786000_50.8.1009.36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev267"},{"key":"2023122105350786000_50.8.1009.37","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.111187"},{"key":"2023122105350786000_50.8.1009.38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40744-020-00197-5","article-title":"Improvement of function and its determinants in a group of axial spondyloarthritis patients treated with TNF inhibitors: a real-life study","volume":"7","author":"Lubrano","year":"2020","journal-title":"Rheumatol Ther"},{"key":"2023122105350786000_50.8.1009.39","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.5609"},{"key":"2023122105350786000_50.8.1009.40","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.38140","article-title":"Tumor necrosis factor \u03b1 inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort","volume":"65","author":"Ciurea","year":"2013","journal-title":"Arthritis Rheumatology"},{"key":"2023122105350786000_50.8.1009.41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081122"},{"key":"2023122105350786000_50.8.1009.42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00296-018-4180-4","article-title":"Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany","volume":"39","author":"Kr\u00fcger","year":"2019","journal-title":"Rheumatol Int"},{"key":"2023122105350786000_50.8.1009.43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/03009742.2018.1481225","article-title":"Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis","volume":"48","author":"Krabbe","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2023122105350786000_50.8.1009.44","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/annrheumdis-2019-215427","article-title":"Treatment response and drug retention rates in 24 195 biologic-na\u00efve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration","volume":"78","author":"\u00d8rnbjerg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2023122105350786000_50.8.1009.45","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.17666"},{"key":"2023122105350786000_50.8.1009.46","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170166"},{"key":"2023122105350786000_50.8.1009.47","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202431"},{"key":"2023122105350786000_50.8.1009.48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2147\/PPA.S162420","article-title":"Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature","volume":"12","author":"Torre-Alonso","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"2023122105350786000_50.8.1009.49","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/rheumatology\/kez119","article-title":"Comorbidity burden in axial spondyloarthritis: a cluster analysis","volume":"58","author":"Zhao","year":"2019","journal-title":"Rheumatology"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.220459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T13:37:20Z","timestamp":1703165840000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.220459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,1]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.3899\/jrheum.220459"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.220459","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}